BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast
,
Early pregnancy factor
,
Doxorubicin
,
rs2476601
,
SLC12A1
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
OR2T2P
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viremia
COVID-19
Tuberculosis
Human papilloma virus infection
Mycobacteriosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
KU 55933
Aclarubicin
Anti-Retroviral Agents
5-(6)-carboxyfluorescein diacetate succinimidyl ester
Pneumovax
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
IRAK4
UBD
CUL3
TAF1
MYCN
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia…
The impact of the Covid-19 pandemic on maternal delivery experiences and breastfeeding practices in …
Risk factors for in-hospital mortality among acute ischemic stroke patients in China: a nationwide p…
Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to ide…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for OR2T2P
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ